Developer docs
API playgroundTry for free, no card

Search company profiles

BlueNalu

Full company profile

uuid0000m5y

Namestring
BlueNalu
Legal namestring
BlueNalu, Inc.
Websiteurl
bluenalu.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

BlueNalu is a San Diego-based cellular aquaculture company founded in 2017 that produces cell-cultivated seafood, beginning with premium bluefin tuna toro. The company grows fish tissue directly from isolated cells using a non-GMO, single-cell suspension line combined with a proprietary lipid-loading technique, and explicitly avoids genetic engineering, plant-based scaffolds, and animal-derived inputs such as Fetal Bovine Serum. Production cycle from cell to plate is approximately five weeks, versus 5-8 years for wild bluefin tuna to reach comparable quality, and the company has transitioned its supply chain from pharmaceutical-grade to food-grade ingredients.

The company operates a B2B revenue model, targeting premium sushi and fine-dining restaurants in Southern California for its initial commercial launch (announced launch partners include Azuki Sushi, Matsu, and Wrench & Rodent Seabasstropub). Pricing is not publicly disclosed, but the company targets price parity with conventional bluefin tuna via its projected 75% gross margin and validated 5x cost reduction. Future revenue streams include technology licensing as global production facilities are built. Distribution is anchored by strategic partnerships with major food and seafood companies — Nomad Foods (UK/Europe), FOOD & LIFE COMPANIES (1,000+ Asia-Pacific sushi restaurants), Mitsubishi Corporation, Pulmuone, Thai Union, Nutreco, Griffith Foods, and Rich Products — providing multi-region market access.

BlueNalu currently operates a ~40,000 sq. ft. pilot facility in San Diego focused on regulatory review and is planning to break ground on a ~140,000 sq. ft. commercial facility capable of producing up to 6 million pounds of premium seafood annually using eight 100,000L bioreactors, with production targeted for 2027. The company has raised approximately $104.5 million in disclosed funding across rounds in 2021, 2023, and 2025-2026, and is pending regulatory approval from the U.S. FDA and within the UK FSA framework before commencing commercial sales.

Short descriptiontext

BlueNalu is a San Diego-based cellular aquaculture company that produces cell-cultivated seafood, beginning with premium bluefin tuna toro, targeting premium sushi and fine-dining restaurants and global markets through strategic partnerships with major food companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell-cultivated seafood, cellular aquaculture, cultivated bluefin tuna, alternative seafood products, food-grade cell culture
Industry2 codes
1Freezing & Cold-Chain Seafood Processing (IQF, Blast Freezing, Glazing)
CodeAFANADAEPrimaryNo
2Aquaculture Harvest, Processing & Packing (Farmed Finfish/Shellfish; On-Farm Plants)
CodeAFANADALPrimaryNo
NAICS code4 codes
  • Aquaculture1125
  • Finfish Farming and Fish Hatcheries112511
  • Seafood Product Preparation and Packaging31171
  • Seafood Product Preparation and Packaging3117
SIC code1 code
  • Prepared Fresh Or Frozen Fish & Seafoods2092
Product category
Cultivated Seafood
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Cell-Cultivated Seafood Product Sales
TypeOne Time License
Description

BlueNalu generates revenue through the sale of cell-cultivated seafood products, initially targeting premium bluefin tuna toro to high-end sushi and fine-dining restaurants. The company plans to expand its product portfolio to include additional species (mahi mahi, other finfish) and formats. Revenue will flow from initial limited-time offerings at select restaurants to broader foodservice distribution.

bluenalu.com
2Technology Licensing (Future)
TypeLicensing Royalties
Description

BlueNalu may pursue technology licensing opportunities as it establishes regional production facilities globally. The company's proprietary platform technology is designed for multi-species capability and could be licensed to partners in different geographic markets.

bluenalu.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BlueNalu manufactures and sells cell-cultivated seafood products, with its first commercial offering being premium bluefin tuna toro produced as uniform 10 oz frozen saku blocks for sushi, sashimi, and fine-dining kitchens. The product is grown directly from isolated fish cells in a clean, controlled environment without genetic engineering, plant-based scaffolds, or antibiotics, and is positioned as a sushi-grade, 100% yield alternative to wild-caught bluefin tuna toro. The company plans to expand its portfolio to additional finfish species such as mahi mahi.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 75% projected gross margin in first year of large-scale production
+5 more records
Product overview1 text field

BlueNalu offers cell-cultivated seafood products, with its first commercial product being premium bluefin tuna toro (saku blocks). The company develops seafood directly from fish cells using proprietary cellular aquaculture technology. Cells are sourced from a one-time tissue sample from wild Pacific bluefin tuna, then cultivated in a clean, controlled environment and formed into uniform saku blocks. BlueNalu's product portfolio is designed to expand to multiple finfish species, with the company having developed hundreds of cell lines for eight different finfish species. The company plans to launch through select premium sushi and fine-dining restaurants in Southern California, expanding to additional U.S. markets and international regions including UK, Europe, Japan, South Korea, and Thailand.

Product and service1 record
1BlueNalu Bluefin Tuna Toro (Saku)
CategoryCell-cultivated seafood
Description

Cell-cultivated bluefin tuna toro offered as uniform 10 oz frozen saku blocks designed for sushi, sashimi, and fine-dining preparations. Produced directly from fish cells grown in a clean, controlled environment without genetic engineering, plant-based scaffolds, or antibiotics, and targeted at premium restaurants that today rely on scarce wild bluefin toro.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-04-29
Description

Expanded strategic partnership with Nomad Foods (parent of Birds Eye, Findus, iglo) to support commercialization of cell-cultivated seafood in UK and Europe. First announced in September 2021, the partnership includes market research, regulatory assessment, and product opportunity exploration. BlueNalu's acceptance into UK FSA regulatory sandbox reinforces this collaboration.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-10-03
Description

Extended MOU with Mitsubishi Corporation (Japan) to facilitate introduction of BlueNalu's cell-cultured seafood across Japan. Partnership focuses on market research, regulatory requirements, and go-to-market strategies. Initial MOU signed in April 2021.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-10-03
Description

Extended MOU with Pulmuone (South Korea) for market development of cell-cultured seafood in Korea. Partnership includes market research, regulatory affairs, and distribution strategies. Initial MOU signed in July 2020, making Pulmuone one of BlueNalu's earliest strategic partners.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-10-03
Description

Extended MOU with Thai Union (Thailand) to develop market entry strategies for cell-cultured seafood in Thailand and broader Southeast Asia. Partnership includes market research, regulatory assessment, and supply chain development. Initial MOU signed in April 2021.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-03-13
Description

Letter of Intent with Nutreco (global animal nutrition and aquafeed leader) to establish and scale-up a food-grade supply chain for cell-cultured seafood manufacturing. Partnership aims to reduce cell feed costs and establish specifications for food-grade raw materials. Nutreco participated in BlueNalu's Series A round in December 2019.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-10-05
Description

Strategic partner and investor in BlueNalu. Griffith Foods is a developer and manufacturer of customized food ingredients and solutions. Dr. Mary Wagner serves on both Griffith Foods' board and BlueNalu's board.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-10-05
Description

Strategic partner in BlueNalu's global network of leading food companies supporting commercialization of cell-cultured seafood products.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2022-01-25
Description

Partnership with Japan's largest sushi restaurant operator (operating Sushiro, Kyotaru brands with 1,000+ restaurants across Japan, Korea, Taiwan, Hong Kong, Singapore, Thailand, China) to develop supply-chain solutions for bluefin tuna and other sushi-grade products in the Asia-Pacific region.

Strategic tierCoreTypeOthersAnnounced on2022-01-05
Description

Former senior executive at Starbucks, Mars, Gallo Winery, Yum! Brands and General Mills appointed as BlueNalu's first independent board director. Former president of the Institute of Food Technologists brings extensive food industry expertise in innovation, quality control, regulatory affairs, and consumer research.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Finless Foods is a US-based cellular aquaculture company developing cell-cultivated bluefin tuna and other seafood. It is BlueNalu's most direct competitor, pursuing the same premium bluefin niche with similar cell-cultivation technology for sushi and sashimi applications.

TypeDirect peer
Description

Upside Foods (formerly Memphis Meats) is a leading cell-cultivated meat company that achieved the first US FDA 'no questions' letter for cultivated chicken. It is comparable to BlueNalu as a peer cultivated-meat platform targeting premium foodservice with a similar regulatory and scale-up playbook, though focused on land-animal proteins.

TypeDirect peer
Description

Wildtype is a cellular aquaculture company producing cell-cultivated salmon for sushi and foodservice. It is a direct peer to BlueNalu in the cultivated seafood category, applying similar cell-line and bioreactor technology to a competing premium fish species with overlapping restaurant customers.

TypeDirect peer
Description

GOOD Meat is the cultivated meat division of Eat Just Inc., producing cell-cultivated chicken with regulatory approvals in Singapore and the US. It is comparable to BlueNalu as a peer cultivated-meat company targeting premium restaurants and navigating the same novel-food regulatory pathways.

TypeDirect peer
Description

Shiok Meats is a Singapore-based cellular aquaculture company developing cell-cultivated shrimp, crab, and lobster. It is comparable to BlueNalu as a peer cultivated-seafood platform addressing premium Asian seafood categories through similar bioreactor-based cell-cultivation technology.

TypeEmerging player
Description

AquaBounty produces genetically engineered AquAdvantage salmon. It is comparable to BlueNalu as another company bringing alternative-production salmon/fish to market, though using a different (transgenic) technology and targeting different retail/foodservice channels.

TypeOthers
Description

Thai Union is one of the world's largest seafood companies (Chicken of the Sea, King Oscar) and is both a BlueNalu strategic partner and an adjacent incumbent in conventional tuna. It is comparable as a counterparty that could either commercialize BlueNalu's products or compete using its own conventional/aquaculture supply chain.

TypeOthers
Description

Nomad Foods is Europe's largest frozen food company (Birds Eye, Findus, iglo) and a BlueNalu commercialization partner. It is comparable as the channel partner that will distribute BlueNalu products into European retail, and as an incumbent frozen-seafood platform assessing cultivated seafood as a category extension.

TypeBroad incumbent
Description

Cargill is a global agribusiness giant with major aquaculture feed, seafood, and alternative-protein businesses. It is comparable as a broad incumbent in the protein and aquaculture supply chain that could acquire, partner with, or compete against BlueNalu in cultivated seafood.

TypeDirect peer
Description

Mosa Meat is a Netherlands-based cultivated meat company producing cell-cultivated beef. It is comparable to BlueNalu as a peer cultivated-meat platform at similar pre-commercial stage, navigating parallel EU novel-food regulation and pursuing premium foodservice accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors35 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BlueNalu

Cultivated Seafoodbluenalu.com

BlueNalu is a San Diego-based cellular aquaculture company that produces cell-cultivated seafood, beginning with premium bluefin tuna toro, targeting premium sushi and fine-dining restaurants and global markets through strategic partnerships with major food companies.

What BlueNalu does

BlueNalu is a San Diego-based cellular aquaculture company founded in 2017 that produces cell-cultivated seafood, beginning with premium bluefin tuna toro. The company grows fish tissue directly from isolated cells using a non-GMO, single-cell suspension line combined with a proprietary lipid-loading technique, and explicitly avoids genetic engineering, plant-based scaffolds, and animal-derived inputs such as Fetal Bovine Serum. Production cycle from cell to plate is approximately five weeks, versus 5-8 years for wild bluefin tuna to reach comparable quality, and the company has transitioned its supply chain from pharmaceutical-grade to food-grade ingredients.

The company operates a B2B revenue model, targeting premium sushi and fine-dining restaurants in Southern California for its initial commercial launch (announced launch partners include Azuki Sushi, Matsu, and Wrench & Rodent Seabasstropub). Pricing is not publicly disclosed, but the company targets price parity with conventional bluefin tuna via its projected 75% gross margin and validated 5x cost reduction. Future revenue streams include technology licensing as global production facilities are built. Distribution is anchored by strategic partnerships with major food and seafood companies — Nomad Foods (UK/Europe), FOOD & LIFE COMPANIES (1,000+ Asia-Pacific sushi restaurants), Mitsubishi Corporation, Pulmuone, Thai Union, Nutreco, Griffith Foods, and Rich Products — providing multi-region market access.

BlueNalu currently operates a ~40,000 sq. ft. pilot facility in San Diego focused on regulatory review and is planning to break ground on a ~140,000 sq. ft. commercial facility capable of producing up to 6 million pounds of premium seafood annually using eight 100,000L bioreactors, with production targeted for 2027. The company has raised approximately $104.5 million in disclosed funding across rounds in 2021, 2023, and 2025-2026, and is pending regulatory approval from the U.S. FDA and within the UK FSA framework before commencing commercial sales.

BlueNalu firmographics

Firmographics
Name
BlueNalu
Legal name
BlueNalu, Inc.
Website
https://bluenalu.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
BlueNalu is a San Diego-based cellular aquaculture company that produces cell-cultivated seafood, beginning with premium bluefin tuna toro, targeting premium sushi and fine-dining restaurants and global markets through strategic partnerships with major food companies.
Ownership category
akta.pro rank

Where BlueNalu is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices3 records

Markets served

BlueNalu business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Cell-Cultivated Seafood Product Sales: BlueNalu generates revenue through the sale of cell-cultivated seafood products, initially targeting premium bluefin tuna toro to high-end sushi and fine-dining restaurants. The company plans to expand its product portfolio to include additional species (mahi mahi, other finfish) and formats. Revenue will flow from initial limited-time offerings at select restaurants to broader foodservice distribution.
  2. Technology Licensing (Future): BlueNalu may pursue technology licensing opportunities as it establishes regional production facilities globally. The company's proprietary platform technology is designed for multi-species capability and could be licensed to partners in different geographic markets.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

BlueNalu product offering

Product offering

Core offering

BlueNalu manufactures and sells cell-cultivated seafood products, with its first commercial offering being premium bluefin tuna toro produced as uniform 10 oz frozen saku blocks for sushi, sashimi, and fine-dining kitchens. The product is grown directly from isolated fish cells in a clean, controlled environment without genetic engineering, plant-based scaffolds, or antibiotics, and is positioned as a sushi-grade, 100% yield alternative to wild-caught bluefin tuna toro. The company plans to expand its portfolio to additional finfish species such as mahi mahi.

Product overview

BlueNalu offers cell-cultivated seafood products, with its first commercial product being premium bluefin tuna toro (saku blocks). The company develops seafood directly from fish cells using proprietary cellular aquaculture technology. Cells are sourced from a one-time tissue sample from wild Pacific bluefin tuna, then cultivated in a clean, controlled environment and formed into uniform saku blocks. BlueNalu's product portfolio is designed to expand to multiple finfish species, with the company having developed hundreds of cell lines for eight different finfish species. The company plans to launch through select premium sushi and fine-dining restaurants in Southern California, expanding to additional U.S. markets and international regions including UK, Europe, Japan, South Korea, and Thailand.

Differentiator

Problem solved

Functional benefit

Products and services

  • BlueNalu Bluefin Tuna Toro (Saku) Cell-cultivated bluefin tuna toro offered as uniform 10 oz frozen saku blocks designed for sushi, sashimi, and fine-dining preparations. Produced directly from fish cells grown in a clean, controlled environment without genetic engineering, plant-based scaffolds, or antibiotics, and targeted at premium restaurants that today rely on scarce wild bluefin toro.

Quantifiable outcome

  • 75% projected gross margin in first year of large-scale production
  • +5 more outcomes

Companies that use BlueNalu

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

BlueNalu technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

BlueNalu partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship and core.

  • Nomad FoodsflagshipStrategic or Co-development Partner · 29 April 2025Expanded strategic partnership with Nomad Foods (parent of Birds Eye, Findus, iglo) to support commercialization of cell-cultivated seafood in UK and Europe. First announced in September 2021, the partnership includes market research, regulatory assessment, and product opportunity exploration. BlueNalu's acceptance into UK FSA regulatory sandbox reinforces this collaboration.
  • Mitsubishi CorporationflagshipStrategic or Co-development Partner · 3 October 2023Extended MOU with Mitsubishi Corporation (Japan) to facilitate introduction of BlueNalu's cell-cultured seafood across Japan. Partnership focuses on market research, regulatory requirements, and go-to-market strategies. Initial MOU signed in April 2021.
  • Pulmuone Co. Ltd.flagshipStrategic or Co-development Partner · 3 October 2023Extended MOU with Pulmuone (South Korea) for market development of cell-cultured seafood in Korea. Partnership includes market research, regulatory affairs, and distribution strategies. Initial MOU signed in July 2020, making Pulmuone one of BlueNalu's earliest strategic partners.
  • Thai UnionflagshipStrategic or Co-development Partner · 3 October 2023Extended MOU with Thai Union (Thailand) to develop market entry strategies for cell-cultured seafood in Thailand and broader Southeast Asia. Partnership includes market research, regulatory assessment, and supply chain development. Initial MOU signed in April 2021.
  • NutrecoflagshipStrategic or Co-development Partner · 13 March 2023Letter of Intent with Nutreco (global animal nutrition and aquafeed leader) to establish and scale-up a food-grade supply chain for cell-cultured seafood manufacturing. Partnership aims to reduce cell feed costs and establish specifications for food-grade raw materials. Nutreco participated in BlueNalu's Series A round in December 2019.
  • Griffith FoodscoreStrategic or Co-development Partner · 5 October 2022Strategic partner and investor in BlueNalu. Griffith Foods is a developer and manufacturer of customized food ingredients and solutions. Dr. Mary Wagner serves on both Griffith Foods' board and BlueNalu's board.
  • Rich Products CorporationcoreStrategic or Co-development Partner · 5 October 2022Strategic partner in BlueNalu's global network of leading food companies supporting commercialization of cell-cultured seafood products.
  • FOOD & LIFE COMPANIESflagshipStrategic or Co-development Partner · 25 January 2022Partnership with Japan's largest sushi restaurant operator (operating Sushiro, Kyotaru brands with 1,000+ restaurants across Japan, Korea, Taiwan, Hong Kong, Singapore, Thailand, China) to develop supply-chain solutions for bluefin tuna and other sushi-grade products in the Asia-Pacific region.
  • Mary K. Wagner, Ph.D.coreOthers · 5 January 2022Former senior executive at Starbucks, Mars, Gallo Winery, Yum! Brands and General Mills appointed as BlueNalu's first independent board director. Former president of the Institute of Food Technologists brings extensive food industry expertise in innovation, quality control, regulatory affairs, and consumer research.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

BlueNalu competitors and assessment

Company assessment

Direct peers

  • Finless Foods: Finless Foods is a US-based cellular aquaculture company developing cell-cultivated bluefin tuna and other seafood. It is BlueNalu's most direct competitor, pursuing the same premium bluefin niche with similar cell-cultivation technology for sushi and sashimi applications.
  • Upside Foods: Upside Foods (formerly Memphis Meats) is a leading cell-cultivated meat company that achieved the first US FDA 'no questions' letter for cultivated chicken. It is comparable to BlueNalu as a peer cultivated-meat platform targeting premium foodservice with a similar regulatory and scale-up playbook, though focused on land-animal proteins.
  • Wildtype: Wildtype is a cellular aquaculture company producing cell-cultivated salmon for sushi and foodservice. It is a direct peer to BlueNalu in the cultivated seafood category, applying similar cell-line and bioreactor technology to a competing premium fish species with overlapping restaurant customers.
  • GOOD Meat (Eat Just): GOOD Meat is the cultivated meat division of Eat Just Inc., producing cell-cultivated chicken with regulatory approvals in Singapore and the US. It is comparable to BlueNalu as a peer cultivated-meat company targeting premium restaurants and navigating the same novel-food regulatory pathways.
  • Shiok Meats: Shiok Meats is a Singapore-based cellular aquaculture company developing cell-cultivated shrimp, crab, and lobster. It is comparable to BlueNalu as a peer cultivated-seafood platform addressing premium Asian seafood categories through similar bioreactor-based cell-cultivation technology.
  • Mosa Meat: Mosa Meat is a Netherlands-based cultivated meat company producing cell-cultivated beef. It is comparable to BlueNalu as a peer cultivated-meat platform at similar pre-commercial stage, navigating parallel EU novel-food regulation and pursuing premium foodservice accounts.

Emerging players

  • AquaBounty Technologies: AquaBounty produces genetically engineered AquAdvantage salmon. It is comparable to BlueNalu as another company bringing alternative-production salmon/fish to market, though using a different (transgenic) technology and targeting different retail/foodservice channels.

Others

  • Thai Union Group: Thai Union is one of the world's largest seafood companies (Chicken of the Sea, King Oscar) and is both a BlueNalu strategic partner and an adjacent incumbent in conventional tuna. It is comparable as a counterparty that could either commercialize BlueNalu's products or compete using its own conventional/aquaculture supply chain.
  • Nomad Foods: Nomad Foods is Europe's largest frozen food company (Birds Eye, Findus, iglo) and a BlueNalu commercialization partner. It is comparable as the channel partner that will distribute BlueNalu products into European retail, and as an incumbent frozen-seafood platform assessing cultivated seafood as a category extension.

Broad incumbents

  • Cargill: Cargill is a global agribusiness giant with major aquaculture feed, seafood, and alternative-protein businesses. It is comparable as a broad incumbent in the protein and aquaculture supply chain that could acquire, partner with, or compete against BlueNalu in cultivated seafood.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

BlueNalu social profiles

Digital presence

BlueNalu compliance and trust

Trust signal

Compliance2 records

BlueNalu financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BlueNalu leadership team

Management profile

Number of profiles

Profiles7 records

BlueNalu funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors35 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BlueNalu M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BlueNalu

What does BlueNalu do?

BlueNalu manufactures and sells cell-cultivated seafood products, with its first commercial offering being premium bluefin tuna toro produced as uniform 10 oz frozen saku blocks for sushi, sashimi, and fine-dining kitchens. The product is grown directly from isolated fish cells in a clean, controlled environment without genetic engineering, plant-based scaffolds, or antibiotics, and is positioned as a sushi-grade, 100% yield alternative to wild-caught bluefin tuna toro. The company plans to expand its portfolio to additional finfish species such as mahi mahi.

Is BlueNalu a public or private company?

BlueNalu is a private company. It is classified as venture growth investor backed and is currently operating.

When was BlueNalu founded?

BlueNalu was founded in 2017. It employs 11 to 50 people.

Where is BlueNalu based?

BlueNalu is headquartered in San Diego, United States, in the North America region.

How does BlueNalu make money?

Two revenue lines are on record. Cell-Cultivated Seafood Product Sales are the primary driver. The others are technology Licensing (Future).

Who are BlueNalu's main competitors?

Direct peers on record are Finless Foods, Upside Foods, Wildtype, GOOD Meat (Eat Just), Shiok Meats and Mosa Meat. AquaBounty Technologies is listed as an emerging player. Others are Thai Union Group and Nomad Foods. Cargill is listed as a broad incumbent.

Does BlueNalu have an API?

No public API is recorded for BlueNalu.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarAgronomics Limited Announces Director/PDMR ShareholdingJim Mellon, Executive Chair of Agronomics Limited, purchased 27,490,407 ordinary shares from BlueNalu for US$2,000,000 on 13 July 2026, plus 6,050,000 market shares between March 2026. His total stake is 199,316,404 shares, representing 18.30% of voting rights. He has no current intention to sell.SeafoodSourcePlant-Based & Cell-BasedSeveral companies involved in plant-based and cell-based seafood and alternative proteins announced developments and partnerships. Notable activities include acquisitions, product launches, funding, and regulatory progress from companies such as BlueNalu, Atlantic Fish, Revo Foods, and Umami Bioworks.The Cool DownCultivated meat barely left the gate, and two of its best-funded startups are already goneInvestment in cultivated meat has collapsed from $989 million in 2021 to just $82.6 million in 2025, with Believer Meats and Meatable—two of the sector's top fundraisers—closing operations in December 2024, while Good Meat and Upside Foods face ongoing production challenges. Industry experts now argue that regulatory approvals alone are insufficient and that the sector must demonstrate commercial viability through paid partnerships and real offtake agreements. Analysts suggest high-end seafood products like cultivated bluefin tuna, exemplified by BlueNalu, may be the most viable near-term path to market due to pricing dynamics favouring premium specialty cuts.Cultivated XFive Alternative Protein Companies Named in TIME’s World’s Top GreenTech RankingTIME magazine, in partnership with data firm Statista, named five alternative protein companies in its second annual World's Top GreenTech Companies ranking of 250 businesses evaluated on environmental impact, financial strength, and innovation. Israeli plant-based meat producer Redefine Meat led the food sector at 22nd overall (score 91.13), followed by UPSIDE Foods (40th), Impossible Foods (59th), BlueNalu (65th), and Dutch cultivated beef company Mosa Meat (91st), which dropped significantly from the top 10 in the prior year's list despite raising €15 million in December 2025. The ranking methodology weighted environmental impact and financial strength at 45% each, with 10% based on patent innovation data from LexisNexis.PreparedfoodsBlueNalu CEO to Keynote NJ FoodTech 2026Rutgers University and its Rutgers Food Innovation Center will host NJ FoodTech 2026, a one-day food technology conference on June 9 in New Brunswick, New Jersey. Lou Cooperhouse, Founder, President & CEO of BlueNalu, will deliver the opening keynote address on company value propositions and product-market fit. In a pre-conference interview, Cooperhouse discussed how capital markets have become more disciplined, innovation cycles have accelerated, and sustainable competitive advantage now requires integrated business ecosystem positioning rather than product features alone.Food Business NewsHeadwinds continue to impede cultivated meat developmentThe cultivated meat sector faced significant headwinds in 2025, with the number of companies declining to 140 from 155 in 2024, and sector funding falling to $73.9 million from $144 million the prior year, according to The Good Food Institute's 2026 State of the Industry report. Several companies consolidated through acquisitions including Nexture Bio acquiring Matrix F.T. and Gourmey merging with Vital Meat to form Parima, while the largest funding rounds included Aleph Farms ($29 million), Mosa Meat ($17.6 million), and BlueNalu ($11 million). Regulatory challenges mounted with seven states implementing bans or moratoriums on cultivated meat sales, and the United States cut $2 million in federal research funding, projections suggest China will surpass the US as the largest R&D funder by 2026, despite some progress in consumer launches and production scaling efforts.SeafoodSourceCell-cultivated seafood makes its debut at Seafood Expo North America as BlueNalu prepares for product launchCell-cultivated seafood company BlueNalu exhibited at the Seafood Expo North America in Boston, marking the debut of cell-cultivated seafood as a third category alongside wild-caught and farmed seafood. The company is awaiting FDA regulatory approval for its bluefin tuna products, expecting clearance within several weeks, which will enable it to launch pre-portioned "saku" blocks to restaurants in San Diego. BlueNalu has developed proprietary technology to grow fish tissue from isolated cells without genetic engineering or scaffolds, positioning itself to scale production at viable costs for the fine dining market.FinSMEsBlueNalu Raises $11M in FundingBlueNalu, a San Diego-based cell-cultured bluefin tuna developer, raised $11M in funding co-led by Agronomics, Siddhi Capital, and Lewis & Clark AgriFood. The company will use the funds to advance its technology toward commercialization and deepen regulatory engagement in the U.S., Singapore, Japan, and the EU.SeafoodSourceBlueNalu garners USD 11 million investment to advance production of cell-cultured bluefin tuna toroCalifornia-based food tech startup BlueNalu secured a USD 11 million investment through convertible note and preferred stock financing led by Agronomics, Siddhi Capital, and Lewis & Clark Agri Food to advance production and commercialization of cell-cultured Bluefin tuna toro. The funding will support manufacturing improvements, regulatory engagement in key global markets, and initial targeting of premium sushi and fine-dining establishments in the United States, pending regulatory approval. BlueNalu's technology eliminates the need to catch or farm fish by growing tuna cells from tissue samples in controlled environments, addressing concerns about overfishing and depleting wild bluefin populations.Fishfarming expertFish-from-cells company raises $11mBlueNalu raised $11 million to advance commercialization of cultivated bluefin tuna. The funding will support regulatory approval, process optimization, and manufacturing readiness for its next-generation facility. The company plans to introduce the product in the US and expand globally.